Scientists say IRX4204 given to mice with evident symptoms showed potential "as a remyelinating and neurorestorative ...

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

myelin sheath stock videos & royalty-free footage Neuron synapse hologram - 3d rendered video of Neuron cell network on black background. Conceptual medical animation. Healthcare concept. SEM [TEM] ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. Autologous ...

Patient enrollment is completed ahead of schedule for Contineum's Phase 2 clinical trial of PIPE-307, an oral remyelination ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

The coincidence of neurofibromatosis 1 and multiple sclerosis might be due to a mutation in the embedded oligodendrocyte-myelin glycoprotein gene.

Pheno Therapeutics has gained clinical trial authorisation (CTA) from the UK's MHRA for its small molecule therapeutic, PTD802.

Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from the UK’s MHRA for its lead candidate, PTD802.

An investigational drug for multiple sclerosis from Io Therapeutics ... disease is caused by the erosion of a protective sheath, made of myelin, that normally surrounds nerve cells.